Free Access
Med Sci (Paris)
Volume 22, Number 1, Janvier 2006
Page(s) 5 - 6
Section Nouvelles
Published online 15 January 2006
  1. Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Ann Rev Immunol 2001; 19 : 131–61. [Google Scholar]
  2. Feutren G, Papoz L, Assan R, et al. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 1986; 2 : 119–24. [Google Scholar]
  3. The Canadian-European Randomized Control Trial Group. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 year of cyclosporin treatment with enhanced insulin secretion. Diabetes 1988; 37 : 1574–82. [Google Scholar]
  4. Chatenoud L, Thervet E, Primo J, et al. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994; 91 : 123–7. [Google Scholar]
  5. Chatenoud L, Primo J, Bach JF. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 1997; 158 : 2947–54. [Google Scholar]
  6. Chatenoud L. CD3-specific antibody-induced active tolerance : from bench to bedside. Nat Rev Immunol 2003; 3 : 123–32. [Google Scholar]
  7. Belghith M, Bluestone JA, Barriot S, et al. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9 : 1202–8. [Google Scholar]
  8. Alegre ML, Peterson LJ, Xu D, et al. A non-activating humanized anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation 1994; 57 : 1537–43. [Google Scholar]
  9. Bolt S, Routledge E, Lloyd I, et al. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur J Immunol 1993; 23 : 403–11. [Google Scholar]
  10. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005; 352 : 2598–608. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.